Search Results 181-190 of 14812 for alt

1. FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study - Mayo Clinic

   AST or ALT >400 U/L. 7. mDF <32 or >70 at Screening 8. MELD score <18 or >25 at Screening. 9. Other causes of liver disease including chronic hepatitis B ...

2. Dual-Hormone Control of Post-absorptive and Post-prandial Glucose in Type 1 Diabetes - Mayo Clinic

   Abnormal liver function test results (ALT >2 times the upper limit of normal). Abnormal renal function test results (creatinine >1.4 in women and >1.5 in ...

3. A Study to Investigate the Effectiveness and Safety of Cannabidiol as an Additional Treatment for Seizures Associated with Lennox-Gastaut Syndrome in Children and Adults - Mayo Clinic

   Alanine aminotransferase [ALT] >5 x upper limit of normal [ULN] or total bilirubin [TBL] >2 x ULN; OR the ALT or Aspartate aminotransferase (AST) >3 x ULN ...

4. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

   ... ALT (SGPT): ≤3 X ULN (participants with active liver metastases who have ALT/AST ≤5 X ULN may be enrolled) * Albumin: ≥2.5 g/dL * ECG: 12-Lead ECG with ...

5. Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia - Mayo Clinic

   Aspartate transaminase (AST) and alanine transaminase (ALT) ≤ 3 x ULN; Calculated creatinine clearance (CrCl) of ≥ 45 mL/min; Life expectancy > 24 weeks ...

6. Study Using Chromogranin A as Surveillance Biomarker in Patients with cARcinoids - Mayo Clinic

   ... (ALT) 1.5 x ULN; Severe liver dysfunction in the presence of liver metastasis defined by AST and ALT over 5 x ULN and total bilirubin over 1.5 x ULN). Severe ...

7. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   Evidence of significant worsening of ALT, AST or bilirubin during the Screening Period, in the opinion of the investigator or medical monitor. A centrally read ...

8. Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma - Mayo Clinic

   ... ALT\]) ≤ 10 x ULN\* * Note: For the purpose of this study, the ULN for SGPT (ALT) has been set to the value of 45 U/L * Shortening fraction of ≥ 27% by ...

9. A Study to Collect Information about Biomarkers (Lab Test Results) that May Help to Predict Which People with Calf Vein Clots May be at Higher or Lower Risk of Having the Clot Grow or Progress - Mayo Clinic

   Significant liver disease (e.g. acute hepatitis, chronic active hepatitis, cirrhosis) or ALT > 3 x ULN. (within last two weeks); Platelet count < 50 x109/L ...

10. PORtopulmonary Hypertension Treatment wIth maCitentan ─ a randOmized Clinical Trial

    ALT/AST >= 3 x ULN; Bilirubin >= 3 mg/dL at Screening; Any known factor or disease that might interfere with treatment compliance, study conduct, or ...